Literature DB >> 32805230

Association of Peripheral Neuropathy with Erectile Dysfunction in US Men.

Caitlin W Hicks1, Dan Wang2, B Gwen Windham3, Elizabeth Selvin2.   

Abstract

BACKGROUND: Peripheral neuropathy and erectile dysfunction are common conditions that have both been linked to cardiovascular disease and its risk factors, especially diabetes. The aim of this study was to assess the association of large-fiber peripheral neuropathy with erectile dysfunction in adult US males with and without diabetes.
METHODS: We included all men aged ≥40 years from the 2001-2002 National Health and Nutrition Examination Survey (NHANES) with data on erectile dysfunction and peripheral neuropathy (n = 1213, including 206 men with diabetes). Erectile dysfunction was assessed by a single question during a self-paced, computer-assisted self-interview. Peripheral neuropathy was evaluated using standardized 10-g monofilament testing, which assesses lower extremity sensation. We used logistic regression to examine the association of peripheral neuropathy with erectile dysfunction overall and stratified by diabetes status, adjusting for demographic and cardiovascular risk factors.
RESULTS: The prevalence of peripheral neuropathy was 26.1% (51.2% in men with diabetes and 22.5% in men without diabetes). There was a significant independent association of peripheral neuropathy with erectile dysfunction overall (odds ratio [OR] 1.71, 95% confidence interval [CI], 1.20-2.43) and among US adult men without diabetes (OR 1.68; 95% CI, 1.11-2.56). The association in adults with diabetes was not statistically significant (OR 1.29; 95% CI, 0.39-4.26), possibly owing to limited power in this subgroup.
CONCLUSIONS: Our study suggests that decreased lower extremity sensation, even in the absence of diabetes, is common and a novel risk factor for erectile dysfunction.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes; Erectile dysfunction; Peripheral neuropathy

Mesh:

Year:  2020        PMID: 32805230      PMCID: PMC7870518          DOI: 10.1016/j.amjmed.2020.07.015

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

1.  Prevalence and risk factors for erectile dysfunction in the US.

Authors:  Elizabeth Selvin; Arthur L Burnett; Elizabeth A Platz
Journal:  Am J Med       Date:  2007-02       Impact factor: 4.965

2.  Erectile dysfunction and subsequent cardiovascular disease.

Authors:  Ian M Thompson; Catherine M Tangen; Phyllis J Goodman; Jeffrey L Probstfield; Carol M Moinpour; Charles A Coltman
Journal:  JAMA       Date:  2005-12-21       Impact factor: 56.272

3.  Cardiovascular autonomic neuropathy, erectile dysfunction and lower urinary tract symptoms in men with type 1 diabetes: findings from the DCCT/EDIC.

Authors:  Rodica Pop-Busui; Jim Hotaling; Barbara H Braffett; Patricia A Cleary; Rodney L Dunn; Catherine L Martin; Alan M Jacobson; Hunter Wessells; Aruna V Sarma
Journal:  J Urol       Date:  2015-01-10       Impact factor: 7.450

Review 4.  Neurologic erectile dysfunction.

Authors:  A Nehra; R B Moreland
Journal:  Urol Clin North Am       Date:  2001-05       Impact factor: 2.241

Review 5.  Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes.

Authors:  Caitlin W Hicks; Elizabeth Selvin
Journal:  Curr Diab Rep       Date:  2019-08-27       Impact factor: 4.810

6.  Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial.

Authors:  Piero Montorsi; Paolo M Ravagnani; Stefano Galli; Francesco Rotatori; Fabrizio Veglia; Alberto Briganti; Andrea Salonia; Federico Dehò; Patrizio Rigatti; Francesco Montorsi; Cesare Fiorentini
Journal:  Eur Heart J       Date:  2006-07-19       Impact factor: 29.983

7.  Diabetic peripheral neuropathy and prevalence of erectile dysfunction in Japanese patients aged <65 years with type 2 diabetes mellitus: The Dogo Study.

Authors:  S Furukawa; T Sakai; T Niiya; H Miyaoka; T Miyake; S Yamamoto; K Maruyama; T Ueda; H Senba; Y Todo; M Torisu; H Minami; M Onji; T Tanigawa; B Matsuura; Y Hiasa; Y Miyake
Journal:  Int J Impot Res       Date:  2016-10-27       Impact factor: 2.896

8.  Associations of Cardiac, Kidney, and Diabetes Biomarkers With Peripheral Neuropathy among Older Adults in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Caitlin W Hicks; Dan Wang; Natalie R Daya; B Gwen Windham; Christie M Ballantyne; Kunihiro Matsushita; Elizabeth Selvin
Journal:  Clin Chem       Date:  2020-05-01       Impact factor: 8.327

9.  Association of peripheral microvascular dysfunction and erectile dysfunction.

Authors:  Rachael E Gerber; Joseph A Vita; Peter Ganz; Carrie G Wager; Andre B Araujo; Raymond C Rosen; Varant Kupelian
Journal:  J Urol       Date:  2014-09-06       Impact factor: 7.450

10.  Small-fibre neuropathy in men with type 1 diabetes and erectile dysfunction: a cross-sectional study.

Authors:  Shazli Azmi; Maryam Ferdousi; Uazman Alam; Ioannis N Petropoulos; Georgios Ponirakis; Andrew Marshall; Omar Asghar; Hassan Fadavi; Wendy Jones; Mitra Tavakoli; Andrew J M Boulton; Maria Jeziorska; Handrean Soran; Nathan Efron; Rayaz A Malik
Journal:  Diabetologia       Date:  2017-03-29       Impact factor: 10.122

  10 in total
  2 in total

1.  The Efficacy of Li-ESWT Combined With VED in Diabetic ED Patients Unresponsive to PDE5is: A Single-Center, Randomized Clinical Trial.

Authors:  Rongzhen Tao; Jianhuai Chen; Dujian Wang; Yunpeng Li; Jun Xiang; Lei Xiong; Junbiao Ji; Jie Wu; Shuang Zhou; Chunping Jia; Jianlin Lv; Jie Yang; Qinglai Tang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

2.  Associations of Peripheral Neuropathy Defined by Monofilament Insensitivity with Mild Cognitive Impairment and Dementia in Older Adults.

Authors:  Caitlin W Hicks; Dan Wang; Andrea L C Schneider; Michelle C Johansen; Rebecca F Gottesman; Kunihiro Matsushita; Josef Coresh; B Gwen Windham; Elizabeth Selvin
Journal:  Dement Geriatr Cogn Disord       Date:  2022-03-28       Impact factor: 3.346

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.